Tag: Atrial Fibrillation
-
DOAC Outcomes in NVAF Linked to Echocardiographic Hemodynamics
Overview: DOACs, NVAF, and the role of cardiac hemodynamics Non-valvular atrial fibrillation (NVAF) requires careful stroke prevention, with direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and dabigatran replacing warfarin in many patients. While DOACs have demonstrated non-inferiority to warfarin in large trials, real-world data reveal nuances in bleeding and stroke risk that may hinge…
-
Genetic Link: ADHD and Autism Raise Heart Disease Risk
Genetic predispositions and heart health: what the study found A comprehensive analysis of genetic data suggests that people with a genetic predisposition to attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) may face an increased risk of certain heart diseases. The study, which combines results from 14 separate investigations and was published in a…
-
Lack of Benefit from Surgical Left Atrial Appendage Occlusion in Non-AF Patients After Valve Surgery
**Understanding Surgical Left Atrial Appendage Occlusion** Surgical left atrial appendage occlusion (LAAO) is a procedure often considered to prevent complications such as ischemic strokes and transient ischemic attacks (TIAs). Traditionally, this procedure is recommended for patients with atrial fibrillation (AF), a condition marked by irregular heartbeats. However, recent studies challenge the utility of LAAO in…
-
Surgical Left Atrial Appendage Occlusion: No Clear Benefits in Non-AF Patients
Recent research has stirred discussions surrounding the efficacy of surgical left atrial appendage (LAA) occlusion in non-atrial fibrillation (AF) patients undergoing valve surgery. Traditionally, LAA occlusion is implemented in patients with AF to mitigate the risk of stroke, transient ischemic attacks (TIA), and cardiovascular mortality. However, findings from a comprehensive study reveal that this approach…